Kilickap S, Baramidze A, Sezer A, Ozguroglu M, et al. Cemiplimab Monotherapy for First-Line Treatment of Patients with Advanced NSCLC With PD-L1 Expression of 50% or Higher: Five-Year Outcomes of EMPOWER-Lung 1. J Thorac Oncol 2025;20:941-954.
PMID: 40118215